Results 191 to 200 of about 71,388 (222)

The significance of endocannabinoid receptors and endocannabinoids in the lower urinary and genital tract. [PDF]

World J Urol
Ückert S, Hedlund P, Tsikas D, Kuczyk MA.   +3 more
europepmc   +1 more source

Behavioral pharmacology of novel synthetic indazole, indole, and benzimidazole cannabinoids in rodents. [PDF]

J Cannabis Res
Shetty RA, Hill RD, McDonald JA, Sumien N, Forster MJ, Gatch MB.   +5 more
europepmc   +1 more source

Establishment of a RBL-formula to determine the retinal breaks location for scleral buckling surgery. [PDF]

Int Ophthalmol
Wang H, Liu F, Hua S, Tang S.
europepmc   +1 more source

Correction: Tetrahydrocannabinol and dopamine D1 receptor. [PDF]

Front Neurosci
Lee J.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

CB1 Cannabinoid Receptor Ligands

Mini-Reviews in Medicinal Chemistry, 2005
The CB1 receptor is expressed in the central nervous system and numerous other tissues including heart, lung and uterus and has been recognized as an important therapeutic target for pain, appetite modulation, glaucoma, multiple sclerosis and other indications.
Ganesh A, Thakur, Spyros P, Nikas, Alexandros, Makriyannis   +2 more
openaire   +2 more sources

Assay of CB1 Receptor Binding

2022
Type-1 cannabinoid receptor (CB1), one of the main targets of endocannabinoids, plays a key role in several pathophysiological conditions that affect both the central nervous system and peripheral tissues. Today, its biochemical identification and pharmacological characterization, as well as the screening of thousands of novel ligands that might be ...
Gasperi V, Savini I, Catani MV
openaire   +3 more sources

The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940)

Behavioural Pharmacology, 2005
It is well established that Cannabis sativa can increase appetite, particularly for sweet and palatable foods. In laboratory animals, cannabinoid CB1 receptor antagonism decreases motivation for palatable foods, and most recently, the CB1 receptor antagonist SR141716A, or rimonabant (Acomplia), was reported to produce weight loss in obese human ...
S J, Ward, L A, Dykstra
openaire   +2 more sources